Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Almost 30% of the study cohort used ADMs periconceptionally
For daily liraglutide, time of day matters more because of the shorter 13-hour half-life
Tirzepatide Side Effects# Well-characterized from Phase 3 (SURPASS, SURMOUNT) trials and post-market surveillance: Gastrointestinal : Nausea (12-33%), diarrhea (12-21%), vomiting (5-12%), constipation (6-11%) Decreased appetite : Common and expected pharmacological effect Injection site reactions : Mild, occurring in 2-5% of patients Pancreatitis : Rare
Severe persistent vomiting, dehydration signs, or severe abdominal pain require immediate medical attention, whilst persistent nausea warrants GP review within 2448 hours
It is a targeted treatment for weight loss and is not indicated for the treatment of type 2 diabetes
US$ 23.28
US$ 26.09
US$ 29.26
US$ 27.25
US$ 27.33
US$ 20.84
US$ 21.17
US$ 26.92
US$ 21.01
US$ 29.50
US$ 22.87
